Suppr超能文献

评估EzeCheck在印度进行血红蛋白筛查的可行性和成本效益。

Evaluating the Feasibility and Cost-Effectiveness of EzeCheck for Hemoglobin Screening Across India.

作者信息

Rajagopal Harshavardhan, Mohakud Nirmal K, Meher Dayanidhi, Ps Balu, Sharma Sonal Deep

机构信息

General Surgery, American Hospital Dubai, Dubai, ARE.

Pediatric Medicine, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.

出版信息

Cureus. 2024 Nov 3;16(11):e72945. doi: 10.7759/cureus.72945. eCollection 2024 Nov.

Abstract

Background Anemia, particularly due to low hemoglobin levels, is a significant public health concern in India. Traditional invasive screening methods can be burdensome and may limit access to diagnosis. This study evaluated the feasibility and cost-effectiveness of a noninvasive hemoglobin screening device called EzeCheck for determining hemoglobin levels across diverse populations in India. We aimed to assess the user feasibility of the EzeCheck device and to conduct a comparative analysis of its cost-effectiveness against other available invasive and noninvasive methods to determine hemoglobin levels. Methods This study adopted a mixed-methods approach, incorporating both quantitative and qualitative data for analysis. User feedback was collected through surveys and interviews with healthcare professionals and workers across various regions. A cost-effectiveness analysis compared the EzeCheck device with other available noninvasive devices and standard invasive methods, accounting for factors such as equipment costs, consumables requirements, time efficiency, and overall testing costs. Results Preliminary findings suggest that the EzeCheck device was well-received by users, with 198 (86%) healthcare professionals reporting improved workflow and patient satisfaction. The comparative analysis revealed that the EzeCheck device was the most affordable option in terms of overall screening costs, while also increasing screening efficiency to a great extent. Moreover, it provided a safer and more comfortable experience for patients and users. Conclusions The noninvasive EzeCheck hemoglobin screening device demonstrates superior feasibility and cost-effectiveness over traditional methods. This study highlights its potential for enhancing anemia detection in India, particularly in underserved areas. By improving accessibility and reducing costs, this device could significantly impact public health outcomes and inform future health policy initiatives.

摘要

背景

贫血,尤其是由于血红蛋白水平低导致的贫血,是印度一个重大的公共卫生问题。传统的侵入性筛查方法可能会带来负担,并且可能限制诊断的可及性。本研究评估了一种名为EzeCheck的非侵入性血红蛋白筛查设备在印度不同人群中测定血红蛋白水平的可行性和成本效益。我们旨在评估EzeCheck设备的用户可行性,并对其与其他现有的侵入性和非侵入性方法测定血红蛋白水平的成本效益进行比较分析。

方法

本研究采用混合方法,纳入定量和定性数据进行分析。通过对不同地区的医疗保健专业人员和工作人员进行调查和访谈来收集用户反馈。成本效益分析将EzeCheck设备与其他现有的非侵入性设备和标准侵入性方法进行比较,考虑设备成本、耗材需求、时间效率和总体检测成本等因素。

结果

初步结果表明,EzeCheck设备受到用户的好评,198名(86%)医疗保健专业人员报告称工作流程得到改善,患者满意度提高。比较分析显示,就总体筛查成本而言,EzeCheck设备是最经济实惠的选择,同时还在很大程度上提高了筛查效率。此外,它为患者和用户提供了更安全、更舒适的体验。

结论

非侵入性的EzeCheck血红蛋白筛查设备在可行性和成本效益方面优于传统方法。本研究突出了其在印度加强贫血检测的潜力,特别是在服务不足的地区。通过提高可及性和降低成本,该设备可能会对公共卫生结果产生重大影响,并为未来的卫生政策举措提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7623/11617121/4a11863d31e0/cureus-0016-00000072945-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验